Tom Smith

Insider profile

Currently holds a position at BioDelivery Sciences International Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer BioDelivery Sciences International Inc July 30, 2018 -
Tom Smith's trades of Collegium Pharmaceutical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
190.70
Quantity 53,943
Value US$2,158,117
Transaction date
Proposed sale
Price
36.61
Quantity 9,220
Value US$337,516
Transaction date
Proposed sale
Price
36.98
Quantity 373
Value US$13,794
Transaction date
Sale
Price
36.76
Quantity 995 -1.5%
Value US$36,580
Transaction date
Proposed sale
Price
36.76
Quantity 995
Value US$36,580
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-03 2025-08-29
S Sale
22,044 +43.6%
78.39
US$2,704,861 		22,044 +43.6% 78.39 US$2,704,861
2025-08-29 2025-08-29
PrS Proposed sale
53,943
190.70
US$2,158,117 		53,943 190.70 US$2,158,117
2024-09-17 2024-09-13
S Sale
91,955 +25.4%
166.68
US$4,175,777 		91,955 +25.4% 166.68 US$4,175,777
2024-09-13 2024-09-13
PrS Proposed sale
9,220
36.61
US$337,516 		9,220 36.61 US$337,516
2024-09-13 2024-09-13
PrS Proposed sale
373
36.98
US$13,794 		373 36.98 US$13,794
2024-03-04 2024-02-29
S Sale
995 -1.5%
36.76
US$36,580 		995 -1.5% 36.76 US$36,580
2024-02-29 2024-02-29
PrS Proposed sale
995
36.76
US$36,580 		995 36.76 US$36,580
2020-02-04 2020-01-31
PlS Planned sale
2,927 -38.2%
5.38
US$15,747 		2,927 -38.2% 5.38 US$15,747